<?xml version="1.0" encoding="UTF-8"?>
<rootTag>
<Award>
<AwardTitle>SBIR Phase I: A Versatile Continuous Adsorption and Simulated Moving Bed (SMB) System for Multi-component Biochemical Purification</AwardTitle>
<AwardEffectiveDate>07/01/2002</AwardEffectiveDate>
<AwardExpirationDate>12/31/2002</AwardExpirationDate>
<AwardTotalIntnAmount>100000.00</AwardTotalIntnAmount>
<AwardAmount>100000</AwardAmount>
<AwardInstrument>
<Value>Standard Grant</Value>
</AwardInstrument>
<Organization>
<Code>07070000</Code>
<Directorate>
<Abbreviation>ENG</Abbreviation>
<LongName>Directorate For Engineering</LongName>
</Directorate>
<Division>
<Abbreviation>IIP</Abbreviation>
<LongName>Div Of Industrial Innovation &amp; Partnersh</LongName>
</Division>
</Organization>
<ProgramOfficer>
<SignBlockName>Om P. Sahai</SignBlockName>
</ProgramOfficer>
<AbstractNarration>This Small Business Innovation Research (SBIR) Phase I Project proposes to develop an integrated software package for the design and optimization of novel Simulated Moving Bed processes for multi-component separation and purification. Innovative design methods, simulation software and equipment have been developed and tested at the laboratory-scale for a number of biological separations, including amino acids, sugars, a peptide drug, an antibiotic, an anticancer drug  and an antiviral drug. Laboratory data show that the new technology can produce high purity (&gt;99%) chemicals at high yield (&gt;99%). When compared to conventional batch chromatography, this technology can increase product yield by 5% to 15%, increase throughput per bed volume and reduce solvent consumption by an order of magnitude. During this Phase I Project, new tools for parameter estimation and cost optimization will be developed and integrated with  existing design and simulation tools. This will result in  a user-friendly interface  for the integrated package. &lt;br/&gt;&lt;br/&gt;The commercial applications of this project are in the area of recovery and purification of pharmaceuticals and other biochemicals. The proposed technology is expected to impact purification costs  in a major way, resulting in annual savings of several million dollars per product.&lt;br/&gt;</AbstractNarration>
<MinAmdLetterDate>06/11/2002</MinAmdLetterDate>
<MaxAmdLetterDate>06/11/2002</MaxAmdLetterDate>
<ARRAAmount/>
<AwardID>0215146</AwardID>
<Investigator>
<FirstName>Nien-Hwa</FirstName>
<LastName>Wang</LastName>
<EmailAddress>nwang@purdue.edu</EmailAddress>
<StartDate>06/11/2002</StartDate>
<EndDate/>
<RoleCode>Principal Investigator</RoleCode>
</Investigator>
<Institution>
<Name>Versachrom, LLC</Name>
<CityName>West Lafayette</CityName>
<ZipCode>479065643</ZipCode>
<PhoneNumber>7655830025</PhoneNumber>
<StreetAddress>20 Brynteg</StreetAddress>
<CountryName>United States</CountryName>
<StateName>Indiana</StateName>
<StateCode>IN</StateCode>
</Institution>
<FoaInformation>
<Code>0510402</Code>
<Name>Biomaterials-Short &amp; Long Terms</Name>
</FoaInformation>
<ProgramElement>
<Code>5371</Code>
<Text>SBIR Phase I</Text>
</ProgramElement>
<ProgramReference>
<Code>9102</Code>
<Text>WOMEN, MINORITY, DISABLED, NEC</Text>
</ProgramReference>
<ProgramReference>
<Code>9181</Code>
<Text>BIOPROCESSING/BIOMOLECULAR MATERIALS</Text>
</ProgramReference>
<ProgramReference>
<Code>BIOT</Code>
<Text>BIOTECHNOLOGY</Text>
</ProgramReference>
</Award>
</rootTag>
